Nicolas Hulscher, MPH
Intramuscular mRNA-1273 injection rapidly crosses the placenta within one hour, accumulates in fetal organs, translates into Spike protein, and persists in fetal tissues after birth.
Here are the key findings:
Rapid Placental Transfer: The study demonstrated that mRNA-1273 crosses the placenta within one hour of maternal vaccination in a mouse model.
Accumulation in Fetal Organs: The mRNA and its lipid nanoparticle (LNP) carriers were detected in fetal blood and tissues (mainly liver), where they persisted beyond initial clearance from maternal circulation.
mRNA Translation into Spike Protein in the Fetus: Fetal tissues actively translated the vaccine mRNA into Spike protein, raising concerns about unintended immune responses or long-term biological effects.
Persistence in Fetal Liver and Spleen: mRNA remained in fetal liver and spleen for at least three weeks postnatally.
This study provides the first in vivo confirmation that mRNA injections cross the placenta, directly reaching the fetus. It also helps explain why these genetic injections pose such serious risks to pregnant women and their unborn children: